Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents

NACompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

December 31, 2018

Conditions
Major Depressive Disorder
Interventions
DEVICE

Active NeuroStar® Transcranial Magnetic Stimulation (TMS)

Compare active NeuroStar® coil with sham NeuroStar® coil.

DEVICE

Sham NeuroStar® Transcranial Magnetic Stimulation (TMS)

Compare active NeuroStar® coil with sham NeuroStar® coil.

Trial Locations (13)

21285

Sheppard Pratt Health System, Baltimore

29425

Medical University of South Carolina, Charleston

32502

Anchor Neuroscience, Pensacola

32606

Florida Clinical Practice Association, Inc., Gainesville

36303

Dothan Behavioral Medicine, Dothan

40222

Integrative Psychiatry, Louisville

43210

The Ohio State University, Columbus

45219

University of Cincinnati College of Medicine, Cincinnati

46601

Beacon Medical Group, South Bend

55905

Mayo Clinic, Rochester

81501

Rocky Mountain TMS, Grand Junction

90024

UCLA, Los Angeles

94305

Stanford University, Palo Alto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Neuronetics

OTHER